Patents by Inventor Jiang Pan

Jiang Pan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11712859
    Abstract: The present disclosure provides a light-weight flexible high-thermal-conductivity nano-carbon composite film and a method for preparing same. The nano-carbon composite film includes a plurality of composite units laminated sequentially. The composite unit includes flexible adhesive layers and a graphene film layer, and the flexible adhesive layers are disposed on both sides of the graphene film layer. The preparation method includes sequentially laminating the composite units and hot pressing to obtain the nano-carbon composite film. The nano-carbon composite film has the characteristics of high thermal conductivity, light weight and flexibility, and has an in-plane thermal conductivity of up to 500 W/m·K or higher, a density of 2.0 g/cm3 or less, and still a thermal conductivity of 500 W/m·K or higher after the nano-carbon composite film is repeatedly bent by 180° for 50 times while there is no peeling of graphene from the surface.
    Type: Grant
    Filed: May 3, 2017
    Date of Patent: August 1, 2023
    Assignee: SHANGHAI COMPOSITES SCIENCE & TECHNOLOGY CO., LTD
    Inventors: Qianli Liu, Feng Shen, Chun Zhuang, Xiaolei Wang, Jiang Pan, Xufeng Hao, Jie Tian
  • Patent number: 11001866
    Abstract: A strain of Burkholderia is Burkholderia glathei ECU0712, with an accession number of CGMCC NO. 14464. With the strain or its extract as the biocatalyst, thioether is catalyzed to be oxidized asymmetrically to chiral sulfoxide, with significant advantages that the obtained product has a high optical purity, and benefits of a simple reaction system, short preparation time of the catalyst and a high yield of the product.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: May 11, 2021
    Assignees: JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD., EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Huilei Yu, Qian Zhao, Yan Zhang, Jiang Pan, Jianhe Xu
  • Publication number: 20200385770
    Abstract: A strain of Burkholderia is Burkholderiaglathei ECU0712, with an accession number of CGMCC NO. 14464. With the strain or its extract as the biocatalyst, thioether is catalyzed to be oxidized asymmetrically to chiral sulfoxide, with significant advantages that the obtained product has a high optical purity, and benefits of a simple reaction system, short preparation time of the catalyst and a high yield of the product.
    Type: Application
    Filed: October 25, 2017
    Publication date: December 10, 2020
    Applicants: JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD., EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Huilei YU, Qian ZHAO, Yan ZHANG, Jiang PAN, Jianhe XU
  • Patent number: 10787651
    Abstract: A Bradyrhizobium monooxygenase, a gene for encoding the monooxygenase, a recombinant expression vector comprising the gene and a recombinant transformant, a method of preparing the monooxygenase by the recombinant expression transformant, and a method of preparing an optically pure chiral sulfoxide by the monooxygenase, in particular to a method of preparing prazole drugs by means of catalyzing the asymmetric oxidation of thioether, a prazole precursor. As compared with other methods of preparing an optically pure sulfoxide, the product produced by the monooxygenase of the present invention as a catalyst has high optical purity, avoids the generation of the byproduct sulfone, and has advantages of mild reaction conditions, simple and convenient operations, easy amplification, etc.
    Type: Grant
    Filed: April 13, 2018
    Date of Patent: September 29, 2020
    Assignees: JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD., EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Huilei Yu, Yan Zhang, Jianhe Xu, Qian Zhao, Jiang Pan, Feng Liu, Guoqiang Lin
  • Patent number: 10762721
    Abstract: Embodiments of the present disclosure disclose an image compositing method and apparatus, used for harmoniously obtaining and displaying a simulation object composited with an accessory, so that a user has desirable experience and visual enjoyment. The apparatus obtains first data of a skeletal model of a simulation object and skeleton data of an accessory to be composited to the simulation object and determines, based on the first data and the skeleton data of the accessory, a target skeleton that is on the skeletal model and that corresponds to the accessory. The apparatus copies first target data of the target skeleton from the first data and adjusts the first target data of the target skeleton based on preconfigured offset data of the target skeleton to obtain first adjusted data. Finally the apparatus performs shading based on the first adjusted data and the first data to obtain the simulation object composited with the accessory.
    Type: Grant
    Filed: March 11, 2019
    Date of Patent: September 1, 2020
    Assignee: TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED
    Inventors: Bing Li, Jiang Pan, Yang Lan
  • Publication number: 20200140830
    Abstract: A Bradyrhizobium monooxygenase, a gene for encoding the monooxygenase, a recombinant expression vector comprising the gene and a recombinant transformant, a method of preparing the monooxygenase by the recombinant expression transformant, and a method of preparing an optically pure chiral sulfoxide by the monooxygenase, in particular to a method of preparing prazole drugs by means of catalyzing the asymmetric oxidation of thioether, a prazole precursor. As compared with other methods of preparing an optically pure sulfoxide, the product produced by the monooxygenase of the present invention as a catalyst has high optical purity, avoids the generation of the byproduct sulfone, and has advantages of mild reaction conditions, simple and convenient operations, easy amplification, etc.
    Type: Application
    Filed: April 13, 2018
    Publication date: May 7, 2020
    Applicants: JIANGSU AOSAIKANG PHARMACEUTICAL CO., LTD., EAST CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY
    Inventors: Huilei YU, Yan ZHANG, Jianhe XU, Qian ZHAO, Jiang PAN, Feng LIU, Guoqiang LIN
  • Publication number: 20190206145
    Abstract: Embodiments of the present disclosure disclose an image compositing method and apparatus, used for harmoniously obtaining and displaying a simulation object composited with an accessory, so that a user has desirable experience and visual enjoyment. The apparatus obtains first data of a skeletal model of a simulation object and skeleton data of an accessory to be composited to the simulation object and determines, based on the first data and the skeleton data of the accessory, a target skeleton that is on the skeletal model and that corresponds to the accessory. The apparatus copies first target data of the target skeleton from the first data and adjusts the first target data of the target skeleton based on preconfigured offset data of the target skeleton to obtain first adjusted data. Finally the apparatus performs shading based on the first adjusted data and the first data to obtain the simulation object composited with the accessory.
    Type: Application
    Filed: March 11, 2019
    Publication date: July 4, 2019
    Inventors: Bing LI, Jiang Pan, Yang Lan
  • Patent number: 10294479
    Abstract: Disclosed herein is Candida parapsilosis CGMCC 9630, the carbonyl reductase expressed by said strain and the encoding gene and amino acid sequence thereof, the recombinant expression vector and recombinant expression transformant containing said gene sequence, and use of whole cells of Candida parapsilosis, carbonyl reductase or corresponding recombinant transformant thereof as catalyst in catalyzing asymmetric reduction of prochiral carbonyl compounds, particularly reduction of 6-carbonyl-8-halogenocaprylate to prepare the synthetic precursor of (R)-?-lipoic acid, (R)-6-hydroxy-8-halogenocaprylate. In comparison to other methods of asymmetric reduction for preparing (R)-6-hydroxy-8-halogenocaprylate, the disclosure has advantages of high substrate concentration, mild reaction conditions, environmental friendship, high yield, and high optical purity of the product, and thus has good prospect in industrial production of (R)-?-?-lipoic acid.
    Type: Grant
    Filed: March 4, 2015
    Date of Patent: May 21, 2019
    Assignee: East China University of Science and Technology
    Inventors: Jianhe Xu, Yujun Zhang, Gaowei Zheng, Jiang Pan
  • Publication number: 20180265875
    Abstract: Disclosed herein is Candida parapsilosis CGMCC 9630, the carbonyl reductase expressed by said strain and the encoding gene and amino acid sequence thereof, the recombinant expression vector and recombinant expression transformant containing said gene sequence, and use of whole cells of Candida parapsilosis, carbonyl reductase or corresponding recombinant transformant thereof as catalyst in catalyzing asymmetric reduction of prochiral carbonyl compounds, particularly reduction of 6-carbonyl-8-halogenocaprylate to prepare the synthetic precursor of (R)-?-lipoic acid, (R)-6-hydroxy-8-halogenocaprylate. In comparison to other methods of asymmetric reduction for preparing (R)-6-hydroxy-8-halogenocaprylate, the disclosure has advantages of high substrate concentration, mild reaction conditions, environmental friendship, high yield, and high optical purity of the product, and thus has good prospect in industrial production of (R)-?-?-lipoic acid.
    Type: Application
    Filed: March 4, 2015
    Publication date: September 20, 2018
    Inventors: Jianhe Xu, Yujun Zhang, Gaowei Zheng, Jiang Pan